The Discounted Cash Flow (DCF) valuation of Biogen Inc (BIIB) is 204.61 USD. With the latest stock price at 133.13 USD, the upside of Biogen Inc based on DCF is 53.7%.
Based on the latest price of 133.13 USD and our DCF valuation, Biogen Inc (BIIB) is a buy. buying Biogen stocks now will result in a potential gain of 53.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 8.9% | 7.8% |
| Long-term Growth Rate | 0.5% - 1.5% | 1.0% |
| Fair Price | 164.52 - 269.07 | 204.61 |
| Upside | 23.6% - 102.1% | 53.7% |